Wholesale of pharmaceutical and medical goods
IMPLANTSCAN AS
Revenue 2024
NOK 20.6m
Operating profit
NOK −782,000
Equity
NOK 1.3m
Incorporated
2006
Employees
5
Share capital
NOK 100,000
Key figures · 2024
Current ratio
0.93
Equity ratio
12.1%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | -3.8% | |
| Net margin (%%) | -4.6% | |
| Return on assets (%%) | -7.4% | |
| Likviditet | ||
| Current ratio | 0.93 | |
| Working capital | −643k | |
| Soliditet | ||
| Equity ratio (%%) | 12.1% | |
| Debt-to-equity ratio | 7.27 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.